CIK: 1655962 - Address: 2000 Sierra Point Parkway, Suite 501, Brisbane, CA 94005
22 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

11/19/24 16:30
11/18/24
DAWNDay One Biopharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsYork Charles N IICAOCOO,CFO,S.d-3413.210-3-1240D
8/19/24 18:07
8/16/24
DAWNDay One Biopharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsYork Charles N IICAOCOO,CFO,S.d-3714.000-3-1232D
5/17/24 18:15
5/16/24
DAWNDay One Biopharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsYork Charles N IICAOCOO,CFO,S.d-4316.080-3-1225D
5/3/24 18:44
5/1/24
DAWNDay One Biopharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsYork Charles N IICAOCOO,CFO,S.m-1,08117.880-60-22217D
2/20/24 18:36
2/16/24
DAWNDay One Biopharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsYork Charles N IICAOCOO,CFO,S.d-4115.250-3-1278D
11/17/23 18:33
11/16/23
DAWNDay One Biopharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsYork Charles N IICAOCOO,CFO,S.d-1111.690-10270D
8/17/23 19:02
8/17/23
DAWNDay One Biopharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsYork Charles N IICAOCOO,CFO,S.d-1313.860-10268D
5/17/23 18:36
5/16/23
DAWNDay One Biopharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsYork Charles N IICAOCOO,CFO,S.d-1313.120-10265D
2/21/23 17:01
2/17/23
DAWNDay One Biopharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsYork Charles N IICAOCOO,CFO,S-18820.030-9-3262D
2/17/23 17:35
2/16/23
DAWNDay One Biopharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsYork Charles N IICAOCOO,CFO,S.d-1819.570-10272D
1/23/23 18:00
1/20/23
DAWNDay One Biopharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsYork Charles N IICAOCOO,CFO,S-22822.750-10-4269D
12/22/22 17:43
12/20/22
DAWNDay One Biopharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsYork Charles N IICAOCOO,CFO,S-20120.070-10-3276D
11/22/22 18:46
11/21/22
DAWNDay One Biopharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsYork Charles N IICAOCOO,CFO,S-20820.760-10-3286D
11/17/22 17:49
11/16/22
DAWNDay One Biopharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsYork Charles N IICAOCOO,CFO,S.d-921.46000296D
11/3/22 17:49
11/1/22
DAWNDay One Biopharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsYork Charles N IICAOCOO,CFO,S-20020.030-10-3294D
10/5/22 16:36
10/3/22
DAWNDay One Biopharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsYork Charles N IICAOCOO,CFO,S-20020.050-10-3304D
9/6/22 19:54
9/1/22
DAWNDay One Biopharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsYork Charles N IICAOCOO,CFO,S-23223.250-10-3314D
8/17/22 19:23
8/16/22
DAWNDay One Biopharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsYork Charles N IICAOCOO,CFO,S.d-2624.310-10324D
8/5/22 17:20
8/4/22
DAWNDay One Biopharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsYork Charles N IICAOCOO,CFO,S-20120.050-10-3321D
7/20/22 18:18
7/18/22
DAWNDay One Biopharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsYork Charles N IICAOCOO,CFO,S-5020.000-3-1331D
7/12/22 19:31
7/8/22
DAWNDay One Biopharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsYork Charles N IICAOCOO,CFO,S-2820.000-10334D
7/6/22 21:00
7/1/22
DAWNDay One Biopharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsYork Charles N IICAOCOO,CFO,S.m-4620.000-2-1335D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact